Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 798

Cynamon MH, Swenson CE, Palmer GS, Ginsberg RS (1989) Liposome-encapsulated-amikacin
therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents
Chemother 33:1179-1183
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M,
Ward M (2000) Chlamydia pneumoniae IgG titres and coronary heart disease: prospective
study and meta-analysis. BMJ 321: 208-213
Dannenberg AMJr (1989) Immune mechanisms in the pathogenesis of pulmonary tuberculosis.
Rev Infect Dis 11(Suppl 2): S369-378
Dasgupta D, Chakraborty P, Basu MK (2000) Ligation of Fc receptor of macrophages stimulates
protein kinase C and anti-leishmanial activity. Mol Cell Biochem 209: 1-8
Davidson PT, Quec LH (1992) Drug treatment of tuberculosis- 1992. Drugs 43: 651-673
Davis ME, Chen Z, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality
for cancer. Nat Rev Drug Discov 7: 771-782
de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida
IC, de Andrade SS, de Andrade JG, Martelli CM (1996) Randomised trial of efficacy of ben-
znidazole in treatment of early Trypanosoma cruzi infection. Lancet 348: 1407-1413
de Cock KM, Wilkinson D (1995) Tuberculosis control in resource-poor countries: alternative
approaches in the era of HIV. Lancet 346: 675-677
Decuzzi P, Godin B, Tanaka T, Lee S-Y, Chiappini C, Liu X, Ferrari M (2010) Size and shape
effects in the biodistribution of intravascularly injected particles. J Control Release 141:
320-327
del Rosal Rabes T, Baquero-Artigao F, Gómez Fernández C, García Miguel MJ, de Lucas Laguna
R (2010) Cartas del editor. Tratamientodelaleishmaniasiscutánea con anfotericinaB liposomal.
An Pediatr (Barc) 73(2):101-111
Demicheli C, Ochoa R, Da Silva JBB, Falcão CA, Rossi-Bergmann B, de Melo AL, Sinisterra RD,
Frézard F (2004) Oral delivery of meglumine antimoniate-cyclodextrin complex for treatment
of leishmaniasis. Antimicrob Agents Chemother 48: 100-103
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander
AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G,
Perl TM, Russell PK, Tonat K (2001) Tularemia as a biological weapon: medical and public
health management. JAMA 285: 2763-2773
Deol P, Khuller GK (1997) Lung specific liposomes: stability, biodistribution and toxicity of
liposomal antitubercular drugs in mice. Biochem Biophys Acta 1334: 161-172
Deol P, Khuller GK, Joshi K (1997) Therapeutic efficacies of isoniazid and rifampin encapsulated
in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in
mice. Antimicrob Agents Chemother 41(6): 1211-1214
Desai SA, Krogstad DJ, McCleskey EW (1993) A nutrient-permeable channel on the intraeryth-
rocytic malaria parasite. Nature 362: 643-646
Desai SA, Rosenberg RL (1997) Pore size of the malaria parasite's nutrient channel. Proc Natl
Acad Sci USA 94: 2045-2049
Descoteaux A, Turco SJ (1999) Glycoconjugates in Leishmania infectivity. Biochim Biophys
Acta 1455: 341-352
Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol
Microbiol Infect Dis 27: 305-318
Dierling AM, Cui Z (2005) Targeting primaquine into liver using chylomicron emulsions for
potential vivax malaria therapy. Int J Pharm 303: 143-152.
Djurkovic-Djakovic O, Romand S, Nobrè R, Couvreur J, Thulliez P (2000) Serologic rebounds
after one-year-long treatment for congenital toxoplasmosis. Pediatr Infect Dis J 19(1):
81-83.
Dos Santos N, Allen C, Doppen A-M, Anantha M, Cox KAK, Gallagher RC, Karlsson G,
Edwards K, Kenner G, Samuels L, Webb MS, Bally MB (2007) Influence of poly(ethylene
glycol) grafting density and polymer length on liposomes: Relating plasma circulation life-
times to protein binding. Biochim Biophys Acta 1768: 1367-1377
Dubey JP (2004) Toxoplasmosis - a waterborne zoonosis . Vet Parasitol 126: 57 - 72